{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T05:25:35Z","timestamp":1792819535282,"version":"4.5.0"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100011878","name":"Flanders","doi-asserted-by":"crossref","award":["1800214N"],"award-info":[{"award-number":["1800214N"]}],"id":[{"id":"10.13039\/501100011878","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Clinical Fellowship of the Netherlands Organization for Health Research and Innovation","award":["90713494"],"award-info":[{"award-number":["90713494"]}]},{"name":"Telethon Italy","award":["GGP13162"],"award-info":[{"award-number":["GGP13162"]}]},{"name":"Italian Ministry of Health","award":["GR-2011-02350583"],"award-info":[{"award-number":["GR-2011-02350583"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.phrs.2016.04.025","type":"journal-article","created":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T15:42:21Z","timestamp":1462117341000},"page":"80-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Clinical research in neonates and infants: Challenges and perspectives"],"prefix":"10.1016","volume":"108","author":[{"given":"Raffaele","family":"Coppini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinno H.P.","family":"Simons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Mugelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Allegaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2016.04.025_bib0005","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1055\/s-0033-1361933","article-title":"Medication use in the neonatal intensive care unit","volume":"31","author":"Hsieh","year":"2014","journal-title":"Am. J. Perinatol."},{"key":"10.1016\/j.phrs.2016.04.025_bib0010","doi-asserted-by":"crossref","first-page":"e228","DOI":"10.1111\/apa.12924","article-title":"Unlicensed and off-label drug use: a prospective study in French NICU","volume":"104","author":"Riou","year":"2015","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.phrs.2016.04.025_bib0015","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1001\/jamapediatrics.2013.4208","article-title":"Drug labeling and exposure in neonates","volume":"168","author":"Laughon","year":"2014","journal-title":"JAMA Pediatr."},{"key":"10.1016\/j.phrs.2016.04.025_bib0020","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1001\/jamapediatrics.2013.4604","article-title":"Newborns, one of the last therapeutic orphans to be adopted","volume":"168","author":"Stiers","year":"2014","journal-title":"JAMA Pediatr."},{"key":"10.1016\/j.phrs.2016.04.025_bib0025","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/cpt.166","article-title":"Neonatal drug therapy: the first frontier of therapeutics for children","volume":"98","author":"Allegaert","year":"2015","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.phrs.2016.04.025_bib0030","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/cpt.149","article-title":"A survey of neonatal pharmacokinetic and pharmacodynamic studies in pediatric drug development","volume":"98","author":"Wang","year":"2015","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.phrs.2016.04.025_bib0035","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1001\/jamapediatrics.2015.1640","article-title":"Global collaboration to develop new and existing drugs for neonates","volume":"169","author":"Davis","year":"2015","journal-title":"JAMA Pediatr."},{"key":"10.1016\/j.phrs.2016.04.025_bib0040","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1365-2125.2009.03484.x","article-title":"Proposals for model-based paediatric medicinal development within the current European Union regulatory framework","volume":"68","author":"Manolis","year":"2009","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.phrs.2016.04.025_bib0045","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/archdischild-2013-303721","article-title":"Towards evidence-based dosing regimens in children on the basis of population pharmacokinetic pharmacodynamic modelling","volume":"99","author":"Admiraal","year":"2014","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.phrs.2016.04.025_bib0050","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1517\/17425255.2016.1147559","article-title":"Quantitative clinical pharmacology practice for optimal use of antibiotics during the neonatal period","volume":"12","author":"Samardzic","year":"2016","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.phrs.2016.04.025_bib0055","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s40262-013-0101-6","article-title":"Amikacin maturation model as a marker of renal maturation to predict glomerular filtration rate and vancomycin clearance in neonates","volume":"52","author":"Zhao","year":"2013","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.phrs.2016.04.025_bib0060","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1007\/s00228-009-0782-9","article-title":"The role of population PK-PD modelling in paediatric clinical research","volume":"67","author":"De Cock","year":"2011","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.phrs.2016.04.025_bib0065","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2165\/11595640-000000000-00000","article-title":"Maturation of the glomerular filtration rate in neonates, as reflected by amikacin clearance","volume":"51","author":"De Cock","year":"2012","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.phrs.2016.04.025_bib0070","doi-asserted-by":"crossref","first-page":"6344","DOI":"10.1128\/AAC.01157-15","article-title":"Prospective evaluation of a model-Based dosing regimen for amikacin in preterm and term neonates in clinical practice","volume":"59","author":"Smits","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.phrs.2016.04.025_bib0075","doi-asserted-by":"crossref","DOI":"10.1002\/jcph.705","article-title":"Pharmacometric approaches to personalize use of primarily renally eliminated antibiotics in preterm and term neonates","author":"Wilbaux","year":"2016","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.phrs.2016.04.025_bib0080","first-page":"15","article-title":"High variability in the dosing of commonly used antibiotics revealed by a Europe-wide point prevalence study: implications for research and dissemination","author":"Metsvaht","year":"2015","journal-title":"BMC Pediatr."},{"key":"10.1016\/j.phrs.2016.04.025_bib0085","doi-asserted-by":"crossref","first-page":"5705","DOI":"10.2174\/1381612821666150901110929","article-title":"The impact of hypothermia on the pharmacokinetics of drugs used in neonates and young infants","volume":"21","author":"Pokorna","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.phrs.2016.04.025_bib0090","doi-asserted-by":"crossref","DOI":"10.1111\/bcp.12883","article-title":"Altered gentamicin pharmacokinetics in term neonates undergoing controlled hypothermia","author":"Bijleveld","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.phrs.2016.04.025_bib0095","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1007\/s11095-013-1197-y","article-title":"A neonatal amikacin covariate model can Be used to predict ontogeny of other drugs eliminated through glomerular filtration in neonates","volume":"31","author":"De Cock","year":"2014","journal-title":"Pharm. Res. Dordr."},{"key":"10.1016\/j.phrs.2016.04.025_bib0100","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1128\/AAC.01968-15","article-title":"Towards rational dosing algorithms for vancomycin in neonates and infants based on population pharmacokinetic modeling","volume":"60","author":"Janssen","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.phrs.2016.04.025_bib0105","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1093\/jac\/dkv052","article-title":"Novel model-based dosing guidelines for gentamicin and tobramycin in preterm and term neonates","volume":"70","author":"Valitalo","year":"2015","journal-title":"J. Antimicrob. Chemoth."},{"key":"10.1016\/j.phrs.2016.04.025_bib0110","unstructured":"A. Ohlsson, R. Walia, S. Shah, Ibuprofen for the treatment of patent ductus arteriosus in preterm and\/or low birth weight infants, The Cochrane database of systematic reviews, 2008, CD003481, 10.1002\/14651858, CD003481, pub3."},{"key":"10.1016\/j.phrs.2016.04.025_bib0115","unstructured":"A. Ohlsson, R. Walia, S.S. Shah, Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants, The Cochrane database of systematic reviews, 2015, 2, CD003481, 10.1002\/14651858, CD003481, pub6."},{"key":"10.1016\/j.phrs.2016.04.025_bib0120","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000335332","article-title":"Oral ibuprofen versus intravenous ibuprofen or intravenous indomethacin for the treatment of patent ductus arteriosus in preterm infants: a systematic review and meta-analysis","volume":"102","author":"Neumann","year":"2012","journal-title":"Neonatology"},{"key":"10.1016\/j.phrs.2016.04.025_bib0125","doi-asserted-by":"crossref","first-page":"75","DOI":"10.5409\/wjcp.v5.i1.75","article-title":"Oral medications regarding their safety and efficacy in the management of patent ductus arteriosus","volume":"5","author":"Oncel","year":"2016","journal-title":"World J. Clin. Pediatr."},{"key":"10.1016\/j.phrs.2016.04.025_bib0130","unstructured":"A. Ohlsson, P.S. Shah, Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low-birth-weight infants, The Cochrane database of systematic reviews, 2015, 3, CD010061, 10.1002\/14651858, CD010061, pub2."},{"key":"10.1016\/j.phrs.2016.04.025_bib0135","doi-asserted-by":"crossref","first-page":"106","DOI":"10.2174\/1574886309999141030142847","article-title":"Safety of therapeutics used in management of patent ductus arteriosus in preterm infants","volume":"10","author":"Oncel","year":"2015","journal-title":"Curr. Drug Saf."},{"key":"10.1016\/j.phrs.2016.04.025_bib0140","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000345337","article-title":"Intravenous paracetamol treatment in the management of patent ductus arteriosus in extremely low birth weight infants","volume":"103","author":"Oncel","year":"2013","journal-title":"Neonatology"},{"key":"10.1016\/j.phrs.2016.04.025_bib0145","doi-asserted-by":"crossref","first-page":"e77888","DOI":"10.1371\/journal.pone.0077888","article-title":"Comparison of oral paracetamol versus ibuprofen in premature infants with patent ductus arteriosus: a randomized controlled trial","volume":"8","author":"Dang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2016.04.025_bib0150","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jpeds.2013.11.008","article-title":"Oral paracetamol versus oral ibuprofen in the management of patent ductus arteriosus in preterm infants: a randomized controlled trial","volume":"164","author":"Oncel","year":"2014","journal-title":"J. Pediatr."},{"key":"10.1016\/j.phrs.2016.04.025_bib0155","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1136\/archdischild-2013-303688","article-title":"Paracetamol to induce ductus arteriosus closure: is it valid?","volume":"98","author":"Allegaert","year":"2013","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.phrs.2016.04.025_bib0160","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/j.1460-9592.2008.02764.x","article-title":"Paracetamol (Acetaminophen): mechanisms of action","volume":"18","author":"Anderson","year":"2008","journal-title":"Paediatr. Anaesth."},{"key":"10.1016\/j.phrs.2016.04.025_bib0165","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10787-013-0172-x","article-title":"The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings","volume":"21","author":"Graham","year":"2013","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.phrs.2016.04.025_bib0170","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1096\/fj.07-8506com","article-title":"Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man","volume":"22","author":"Hinz","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.phrs.2016.04.025_bib0175","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.06.2011.4404","article-title":"Early detection of microcirculatory perfusion changes with a high resolution, real time laser Doppler imaging camera\u2013frostbite case study","volume":"2011","author":"Erba","year":"2011","journal-title":"BMJ Case Reports"},{"key":"10.1016\/j.phrs.2016.04.025_bib0180","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.curtheres.2014.12.001","article-title":"Clinical pharmacology of paracetamol in neonates: a review","volume":"77","author":"Pacifici","year":"2015","journal-title":"Curr. Ther. Res. Clin. Exp."},{"key":"10.1016\/j.phrs.2016.04.025_bib0185","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/toxsci\/kft329","article-title":"Paracetamol (Acetaminophen) administration during neonatal brain development affects cognitive function and alters its analgesic and anxiolytic response in adult male mice","volume":"138","author":"Viberg","year":"2014","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.phrs.2016.04.025_bib0190","article-title":"Maternal use of acetaminophen during pregnancy and risk of autism spectrum disorders in childhood: a Danish national birth cohort study","author":"Liew","year":"2015","journal-title":"Autism Res.: Off. J. Int. Soc."},{"key":"10.1016\/j.phrs.2016.04.025_bib0195","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1001\/jamapediatrics.2013.4914","article-title":"Acetaminophen use during pregnancy, behavioral problems, and hyperkinetic disorders","volume":"168","author":"Liew","year":"2014","journal-title":"JAMA Pediatr."},{"key":"10.1016\/j.phrs.2016.04.025_bib0200","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.mehy.2015.11.012","article-title":"Possible effects of repeated exposure to ibuprofen and acetaminophen on the intestinal immune response in young infants","volume":"87","author":"Langhendries","year":"2016","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.phrs.2016.04.025_bib0205","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1001\/jama.1996.03530310045031","article-title":"Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants","volume":"275","author":"Varvarigou","year":"1996","journal-title":"JAMA J. Am. Med. Assoc."},{"key":"10.1016\/j.phrs.2016.04.025_bib0210","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1365-2125.2008.03118.x","article-title":"An optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamic study","volume":"65","author":"Hirt","year":"2008","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.phrs.2016.04.025_bib0215","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s00246-012-0474-6","article-title":"A multi-institutional analysis of inpatient treatment for supraventricular tachycardia in newborns and infants","volume":"34","author":"Seslar","year":"2013","journal-title":"Pediatr. Cardiol."},{"key":"10.1016\/j.phrs.2016.04.025_bib0220","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0002-8703(96)90052-6","article-title":"Efficacy and risks of medical therapy for supraventricular tachycardia in neonates and infants","volume":"131","author":"Weindling","year":"1996","journal-title":"Am. Heart J."},{"issue":"Suppl. 3","key":"10.1016\/j.phrs.2016.04.025_bib0225","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3109\/14767058.2010.517937","article-title":"Supraventricular tachycardia in neonates: antiarrhythmic drug choice dilemma","volume":"23","author":"Tavera","year":"2010","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"10.1016\/j.phrs.2016.04.025_bib0230","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00246-005-1126-x","article-title":"Medications used to manage supraventricular tachycardia in the infant\u2014a North American survey","volume":"27","author":"Wong","year":"2006","journal-title":"Pediatr. Cardiol."},{"key":"10.1016\/j.phrs.2016.04.025_bib0235","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1161\/CIRCEP.112.972620","article-title":"The study of antiarrhythmic medications in infancy (SAMIS) a multicenter, randomized controlled trial comparing the efficacy and safety of digoxin versus propranolol for prophylaxis of supraventricular tachycardia in infants","volume":"5","author":"Sanatani","year":"2012","journal-title":"Circ. Arrhythmia Elec."},{"key":"10.1016\/j.phrs.2016.04.025_bib0240","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/PCC.0000000000000229","article-title":"Comparative effectiveness of digoxin and propranolol for supraventricular tachycardia in infants","volume":"15","author":"Hornik","year":"2014","journal-title":"Pediatr. Crit. Care Med."},{"key":"10.1016\/j.phrs.2016.04.025_bib0245","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1017\/S1047951114001619","article-title":"Efficacy of digoxin in comparison with propranolol for treatment of infant supraventricular tachycardia: analysis of a large, national database","volume":"25","author":"Moffett","year":"2015","journal-title":"Cardiol. Young"},{"key":"10.1016\/j.phrs.2016.04.025_bib0250","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jpeds.2014.08.067","article-title":"Efficacy and safety of high-dose propranolol for the management of infant supraventricular tachyarrhythmias","volume":"166","author":"Barton","year":"2015","journal-title":"J. Pediatr."},{"key":"10.1016\/j.phrs.2016.04.025_bib0255","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1161\/01.CIR.0000132482.95686.87","article-title":"Digoxin in the management of cardiovascular disorders","volume":"109","author":"Gheorghiade","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2016.04.025_bib0260","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1161\/01.CIR.51.2.251","article-title":"Effect of digoxin on atioventricular conduction: studies in patients with and without cardiac autonomic innervation","volume":"51","author":"Goodman","year":"1975","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2016.04.025_bib0265","doi-asserted-by":"crossref","first-page":"782","DOI":"10.2174\/138161208784007743","article-title":"Collateral effects of antiarrhythmics in pediatric age","volume":"14","author":"Ali","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.phrs.2016.04.025_bib0270","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1254\/jphs.13233FP","article-title":"Population pharmacokinetic analysis of digoxin in Chinese neonates and infants","volume":"125","author":"Gong","year":"2014","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.phrs.2016.04.025_bib0275","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1177\/0091270010374475","article-title":"Population pharmacokinetic investigation of digoxin in Japanese infants and young children","volume":"51","author":"Yukawa","year":"2011","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.phrs.2016.04.025_bib0280","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.2174\/1381612811209023119","article-title":"Pharmacokinetics of drugs in neonates: pattern recognition beyond compound specific observations","volume":"18","author":"Smits","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.phrs.2016.04.025_bib0285","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1124\/mol.110.070680","article-title":"Functional maturation of drug transporters in the developing, neonatal, and postnatal kidney","volume":"80","author":"Sweeney","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.phrs.2016.04.025_bib0290","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2174\/1574887109666140908125158","article-title":"Beta-blockers in pediatric hypertrophic cardiomyopathies","volume":"9","author":"Ostman-Smith","year":"2014","journal-title":"Rev. Recent Clin. Trials"},{"key":"10.1016\/j.phrs.2016.04.025_bib0295","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1161\/01.CIR.65.7.1388","article-title":"Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients","volume":"65","author":"Maron","year":"1982","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2016.04.025_bib0300","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1056\/NEJM197110072851507","article-title":"Hypertrophic obstructive cardiomyopathy in an infant\u2013propranolol therapy for three years","volume":"285","author":"Shand","year":"1971","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2016.04.025_bib0305","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1016\/S0735-1097(99)00421-0","article-title":"A cohort study of childhood hypertrophic cardiomyopathy: improved survival following high-dose beta-adrenoceptor antagonist treatment","volume":"34","author":"Ostman-Smith","year":"1999","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2016.04.025_bib0310","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1161\/01.CIR.79.4.836","article-title":"Cardiac norepinephrine kinetics in hypertrophic cardiomyopathy","volume":"79","author":"Brush","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2016.04.025_bib0315","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1111\/j.1476-5381.1995.tb17230.x","article-title":"Reduction by oral propranolol treatment of left ventricular hypertrophy secondary to pressure-overload in the rat","volume":"116","author":"Ostman-Smith","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.04.025_bib0320","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1136\/hrt.77.3.229","article-title":"A regional study of presentation and outcome of hypertrophic cardiomyopathy in infants","volume":"77","author":"Skinner","year":"1997","journal-title":"Heart"},{"key":"10.1016\/j.phrs.2016.04.025_bib0325","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jacc.2009.03.051","article-title":"Risk factors and mode of death in isolated hypertrophic cardiomyopathy in children","volume":"54","author":"Decker","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2016.04.025_bib0330","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/0002-8703(85)90357-6","article-title":"Effect of propranolol on left ventricular relaxation in hypertrophic cardiomyopathy: an echographic study","volume":"109","author":"Bourmayan","year":"1985","journal-title":"Am. Heart J."},{"key":"10.1016\/j.phrs.2016.04.025_bib0335","doi-asserted-by":"crossref","first-page":"291a","DOI":"10.1016\/j.bpj.2014.11.1588","article-title":"Life-Long treatment with late sodium current blocker reduces myocardial dysfunction and remodeling in a mouse model of hypertrophic cardiomyopathy","volume":"108","author":"Gentile","year":"2015","journal-title":"Biophys. J."},{"key":"10.1016\/j.phrs.2016.04.025_bib0340","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1161\/CIRCULATIONAHA.112.134932","article-title":"Late sodium current inhibition reverses electromechanical dysfunction in human hypertrophic cardiomyopathy","volume":"127","author":"Coppini","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2016.04.025_bib0345","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/eurheartj\/ehs150","article-title":"Pharmacological treatment options for hypertrophic cardiomyopathy: high time for evidence","volume":"33","author":"Spoladore","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.phrs.2016.04.025_bib0350","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1472-8206.2010.00869.x","article-title":"Hypertrophic cardiomyopathy in childhood and adolescence\u2014strategies to prevent sudden death","volume":"24","author":"Ostman-Smith","year":"2010","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.phrs.2016.04.025_bib0355","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1365-2125.2007.03046.x","article-title":"Population pharmacokinetics and dose simulation of carvedilol in paediatric patients with congestive heart failure","volume":"65","author":"Albers","year":"2008","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.phrs.2016.04.025_bib0360","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1161\/01.CIR.79.4.836","article-title":"Cardiac norepinephrine kinetics in hypertrophic cardiomyopathy","volume":"79","author":"Brush","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2016.04.025_bib0365","doi-asserted-by":"crossref","first-page":"689","DOI":"10.2165\/11318030-000000000-00000","article-title":"Polymorphism of human cytochrome P450 2D6 and its clinical significance part I","volume":"48","author":"Zhou","year":"2009","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.phrs.2016.04.025_bib0370","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3109\/14767058.2012.755169","article-title":"Propranolol concentrations after oral administration in term and preterm neonates","volume":"26","author":"Filippi","year":"2013","journal-title":"J. Matern. Fetal Neo. Med."},{"key":"10.1016\/j.phrs.2016.04.025_bib0375","doi-asserted-by":"crossref","first-page":"5680","DOI":"10.2174\/1381612821666150901110341","article-title":"Why are excipients important to neonates","volume":"21","author":"Turner","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.phrs.2016.04.025_bib0380","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.earlhumdev.2011.08.014","article-title":"Neonatal drug development","volume":"87","author":"Turner","year":"2011","journal-title":"Early Hum. Dev."},{"key":"10.1016\/j.phrs.2016.04.025_bib0385","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s40262-015-0313-z","article-title":"Challenges associated with route of administration in neonatal drug delivery","volume":"55","author":"Linakis","year":"2016","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.phrs.2016.04.025_bib0390","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2125.2005.02530.x","article-title":"Limited predictability of amikacin clearance in extreme premature neonates at birth","volume":"61","author":"Allegaert","year":"2006","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.phrs.2016.04.025_bib0395","author":"Campino","year":"2015","journal-title":"Strategies implementation to reduce medicine preparation error rate in neonatal intensive care units Eur. J. Pediatr."},{"key":"10.1016\/j.phrs.2016.04.025_bib0400","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1136\/archdischild-2014-307793","article-title":"Potentially harmful excipients in neonatal medicines: a pan-European observational study","volume":"100","author":"Nellis","year":"2015","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.phrs.2016.04.025_bib0405","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.jpeds.2015.07.010","article-title":"Acceptability of uncoated mini-tablets in Neonates\u2014a randomized controlled trial","volume":"167","author":"Klingmann","year":"2015","journal-title":"J. Pediatr."},{"key":"10.1016\/j.phrs.2016.04.025_bib0410","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1136\/adc.2010.190330","article-title":"Prospective assessment of short-term propylene glycol tolerance in neonates","volume":"95","author":"Allegaert","year":"2010","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.phrs.2016.04.025_bib0415","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1365-2125.2012.04312.x","article-title":"Developmental pharmacokinetics of propylene glycol in preterm and term neonates","volume":"75","author":"De Cock","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.phrs.2016.04.025_bib0420","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1007\/s11095-014-1520-2","article-title":"An observational study of blood concentrations and kinetics of methyl- and propyl-parabens in neonates","volume":"32","author":"Mulla","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.phrs.2016.04.025_bib0425","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1001\/jamapediatrics.2015.1640","article-title":"Global collaboration to develop new and existing drugs for neonates","volume":"169","author":"Davis","year":"2015","journal-title":"JAMA Pediatr."},{"key":"10.1016\/j.phrs.2016.04.025_bib0430","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s40272-014-0099-8","article-title":"Ethics of drug studies in the newborn","volume":"17","author":"Ward","year":"2015","journal-title":"Paediatr. Drugs"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816303711?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816303711?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T20:05:27Z","timestamp":1589659527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661816303711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":86,"alternative-id":["S1043661816303711"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2016.04.025","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical research in neonates and infants: Challenges and perspectives","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2016.04.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}